Finance

Beta
Lists
NV40:FRA
Cellectar Biosciences Inc
€0.25
0.00%
(0.00) 1D
Jun 24, 8:08:19 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for NV40...
Mkt. cap
19.91M
Volume
0.00
52-wk high
€315.00
52-wk low
€0.25
No. of employees
11
Mkt. cap
19.91M
Volume
0.00
52-wk high
€315.00
52-wk low
€0.25
No. of employees
11
News stories
From sources across the web
About Cellectar Biosciences Inc
CEO-
Employees11
Founded1996
HeadquartersFlorham Park, New Jersey, United States
SectorBiotechnology
Websitecellectar.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2.39M
2.52M
3.16M
3.01M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.65M
2.33M
2.53M
2.79M
Operating expense
6.04M
4.85M
5.69M
5.79M
Total operating expenses
6.04M
4.85M
5.69M
5.79M
Operating income
-6.04M
-4.85M
-5.69M
-5.79M
Other non operating income
501.60K
294.28K
297.83K
77.00K
EBT including unusual items
-5.45M
-4.44M
-5.30M
-5.65M
EBT excluding unusual items
-5.45M
-4.44M
-5.30M
-5.65M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-5.45M
-4.44M
-5.30M
-5.65M
Net profit margin
-
-
-
-
Earnings per share
-3.39
-1.41
-0.53
-1.33
Interest and investment income
88.02K
112.54K
97.58K
63.00K
Interest expense
-
-
-
-
Net interest expenses
88.02K
112.54K
97.58K
63.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-5.98M
-4.80M
-5.64M
-5.74M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer